NCT00960128 - Observational Prospective Study on Patients Treated With Norditropin® | Biotech Hunter

Enrollment

21,249

Participants

Timeline

Start Date

April 1, 2006

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Growth Hormone DisorderGrowth Hormone Deficiency in ChildrenAdult Growth Hormone DeficiencyGenetic DisorderTurner SyndromeFoetal Growth ProblemSmall for Gestational AgeChronic Kidney DiseaseChronic Renal InsufficiencyNoonan Syndrome

Interventions

DRUG

somatropin

The effectiveness and safety data collection with the use of Norditropin® in daily clinical practice with adults.

DRUG

somatropin

The effectiveness and safety data collection with the use of Norditropin® in daily clinical practice with children.

Trial Locations (23)

1025

Novo Nordisk Investigational Site, Budapest

1070

Novo Nordisk Investigational Site, Brussels

1309

Novo Nordisk Investigational Site, Rud

2300

Novo Nordisk Investigational Site, Copenhagen S

3542

Novo Nordisk Investigational Site, Riyadh

16000

Novo Nordisk Investigational Site, Prague

28033

Novo Nordisk Investigational Site, Madrid

44425

Novo Nordisk Investigational Site, Kfar Saba

55127

Novo Nordisk Investigational Site, Mainz

92932

Novo Nordisk Investigational Site, Paris La Défense Cedex

119330

Novo Nordisk Investigational Site, Moscow

B1636DSU

Novo Nordisk Investigational Site, Prov. de Buenos Aires

FI-02600

Novo Nordisk Investigational Site, Espoo

Unknown

Novo Nordisk Investigational Site, Dublin

Novo Nordisk Investigational Site, Luxembourg

Novo Nordisk Investigational Site, Alphen aan den Rijn

00144

Novo Nordisk Investigational Site, Rome

01112

Novo Nordisk Investigational Site, Vilnius

11 070

Novo Nordisk Investigational Site, Belgrade

SI-1000

Novo Nordisk Investigational Site, Ljubljana

202 15

Novo Nordisk Investigational Site, Malmo

CH-8050

Novo Nordisk Investigational Site, Zurich

RH11 9RT

Novo Nordisk Investigational Site, Crawley